HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yin-Hsiu Chien Selected Research

3-methoxytyrosine

1/20163-O-methyldopa levels in newborns: Result of newborn screening for aromatic l-amino-acid decarboxylase deficiency.
4/2014Diagnosis of aromatic L-amino acid decarboxylase deficiency by measuring 3-O-methyldopa concentrations in dried blood spots.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yin-Hsiu Chien Research Topics

Disease

32Glycogen Storage Disease Type II (Pompe's Disease)
01/2022 - 09/2006
8Fabry Disease (Fabry's Disease)
01/2020 - 10/2009
6Gaucher Disease (Gaucher's Disease)
06/2022 - 09/2002
5Mucopolysaccharidoses
11/2020 - 12/2010
5Methylmalonic acidemia
01/2019 - 05/2003
5Hypermethioninemia
01/2017 - 06/2005
4Muscle Hypotonia (Hypotonia)
04/2022 - 06/2011
4Phenylketonurias (Phenylketonuria)
01/2020 - 11/2004
4Cardiomyopathies (Cardiomyopathy)
06/2018 - 09/2007
3Aromatic amino acid decarboxylase deficiency
01/2022 - 04/2014
3Adult-onset citrullinemia type 2
01/2022 - 08/2006
3Metabolic Diseases (Metabolic Disease)
11/2020 - 05/2013
3Muscular Diseases (Myopathy)
06/2017 - 11/2007
3Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
02/2015 - 09/2013
3Inborn Errors Metabolism (Inborn Errors of Metabolism)
01/2014 - 09/2005
2Lymphadenopathy
06/2022 - 08/2005
2Neuromuscular Diseases (Neuromuscular Disease)
07/2021 - 01/2013
2Mucopolysaccharidosis IV (Morquio Syndrome)
01/2020 - 03/2013
2Propionic Acidemia
01/2019 - 10/2014
2Lymphopenia (Lymphocytopenia)
01/2019 - 01/2015
2Hypothyroidism
01/2018 - 01/2011
2Alzheimer Disease (Alzheimer's Disease)
07/2017 - 01/2016
2Down Syndrome (Down's Syndrome)
07/2017 - 01/2016
2Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
01/2016 - 12/2010
2Bronchiectasis
02/2015 - 06/2014
2Pneumonia (Pneumonitis)
02/2015 - 09/2013
2Maple Syrup Urine Disease
01/2014 - 10/2010
2Glycogen Storage Disease (Glycogenosis)
02/2013 - 06/2009
2Multiple Acyl Coenzyme A Dehydrogenase Deficiency
01/2013 - 10/2011
2VLCAD deficiency
01/2013 - 08/2012
2Medium chain acyl CoA dehydrogenase deficiency
01/2013 - 10/2010
2Citrullinemia
07/2011 - 10/2010
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2011 - 05/2010
2Seizures (Absence Seizure)
07/2009 - 06/2002
2Infections
06/2009 - 09/2005
2Obesity
02/2009 - 02/2007
2Neonatal-onset citrullinemia type 2
08/2008 - 08/2006
1Insulin Resistance
02/2022
1Dyslipidemias (Dyslipidemia)
02/2022
1Methylenetetrahydrofolate reductase deficiency
01/2022
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021
1Myocardial Infarction
12/2021
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
11/2021

Drug/Important Bio-Agent (IBA)

17AcidsIBA
12/2021 - 09/2007
14GlycogenIBA
12/2021 - 09/2006
12EnzymesIBA
12/2021 - 09/2007
9GlucosidasesIBA
12/2021 - 06/2011
8alpha-Glucosidases (Acid Maltase)IBA
01/2015 - 09/2007
7human GAA protein (Myozyme)FDA Link
12/2021 - 09/2007
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
5Pharmaceutical PreparationsIBA
06/2017 - 09/2007
4DNA (Deoxyribonucleic Acid)IBA
02/2014 - 05/2006
4Fatty Acids (Saturated Fatty Acids)IBA
10/2011 - 07/2003
3Insulin (Novolin)FDA Link
02/2022 - 02/2009
3Methionine (L-Methionine)FDA Link
01/2022 - 06/2005
3Phenylalanine (L-Phenylalanine)FDA Link
01/2020 - 11/2004
3Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
01/2020 - 11/2004
3alpha-Galactosidase (Beano)IBA
11/2016 - 10/2009
3Immunoglobulin G (IgG)IBA
02/2015 - 09/2013
3Intravenous Immunoglobulins (IVIG)FDA Link
02/2015 - 03/2003
3Carnitine (L-Carnitine)FDA LinkGeneric
02/2013 - 08/2006
3GlycosphingolipidsIBA
07/2012 - 10/2009
3imigluceraseFDA Link
09/2010 - 09/2002
2Glucose (Dextrose)FDA LinkGeneric
02/2022 - 02/2009
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2022 - 01/2018
2CitrullineIBA
01/2022 - 02/2013
2GlycosaminoglycansIBA
11/2020 - 03/2013
2Lysergic Acid Diethylamide (LSD)IBA
01/2020 - 04/2010
2Hemoglobins (Hemoglobin)IBA
02/2016 - 09/2002
23-methoxytyrosineIBA
01/2016 - 04/2014
2N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA
01/2016 - 12/2010
2Immunoglobulin M (IgM)IBA
02/2015 - 09/2013
2CD40 Ligand (CD40L)IBA
02/2015 - 09/2013
2Immunoglobulin A (IgA)IBA
02/2015 - 09/2013
2globotriaosyl lysosphingolipidIBA
09/2013 - 07/2013
23-methylcrotonyl CoA carboxylase 1 deficiencyIBA
05/2013 - 10/2010
2Systemic carnitine deficiencyIBA
02/2013 - 01/2013
2Mitochondrial DNA (mtDNA)IBA
08/2012 - 11/2002
2GalactosidasesIBA
07/2012 - 01/2011
2citrinIBA
07/2011 - 08/2006
2CreatinineIBA
01/2011 - 01/2011
2Growth Hormone (Somatotropin)IBA
01/2011 - 02/2007
2chitotriosidaseIBA
09/2010 - 01/2010
2Proteins (Proteins, Gene)FDA Link
07/2008 - 08/2005
1eliglustatIBA
06/2022
1MagnesiumIBA
04/2022
1Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
04/2022
1Triglycerides (Triacylglycerol)IBA
02/2022
1HDL LipoproteinsIBA
02/2022
1LipidsIBA
02/2022
1HomocysteineIBA
01/2022
1TubulinIBA
12/2021
1nusinersenIBA
11/2021

Therapy/Procedure

20Enzyme Replacement Therapy
06/2022 - 09/2002
13Therapeutics
01/2022 - 03/2003
3Drug Therapy (Chemotherapy)
07/2021 - 08/2005
3Liver Transplantation
01/2019 - 05/2003
2Aftercare (After-Treatment)
12/2017 - 05/2010
2Transplantation
08/2008 - 09/2005
2Splenectomy
08/2005 - 06/2005